Fact CheckerSign in

NCT07398495Recruiting

Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia

Effects of Multimodal Training on Muscle Function and Glucose Metabolism in Middle-Aged and Older Adults With Type 2 Diabetes Mellitus and Sarcopenia

Source: ClinicalTrials.gov · Last updated 30 Mar 2026

Brief summary (registry, in English)

This study aims to investigate the effects of a 12-week multimodal exercise intervention on middle-aged and older adults (aged 45\~85 years) with Type 2 Diabetes Mellitus (T2DM). The program combines supervised training, home-based sessions, and digital support to improve muscle function, physical performance, metabolic control, and quality of life.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
128 (estimated)
First submitted
4 Feb 2026
Start date
23 Feb 2026
Primary completion date
15 May 2026
Lead sponsor
yueh chu wu
NCT number
NCT07398495

What you commit to

  • Study type: Interventional
  • Planned participants: 128
  • From 23 Feb 2026 to the primary completion date, 15 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • • Limited limb or joint function that prevents exercise (e.g., recent fractures or dislocations).
    • Communication barriers or severe emotional/psychological issues (e.g., uncontrolled depression or severe mental illness).
    • Severe cognitive impairment (e.g., dementia).
    • End-stage renal disease (ESRD).
    • Major comorbidities or complications, including active diabetic foot ulcers, amputation, recent myocardial infarction, severe autonomic neuropathy, or a history of stroke within the last 3 years.

Who the study is looking for

  • Diagnosed with both Type 2 Diabetes Mellitus (T2DM) and sarcopenia.
  • Maintained on a stable regimen of oral hypoglycemic agents.
  • Aged 45 years or older.
  • Capable of communicating effectively in Mandarin or Taiwanese.
  • Willing to provide informed consent or have it obtained from a legally authorized representative.

Age in the registry: 45 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chung Shan Medical University Hospital
Coordinator of this site? Confirm its status
TaichungTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.